Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: Health Evaluation in African Americans Using RAS Therapy [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating safety and health outcomes of RAS Therapy in African American individuals with Alzheimer's diseas…
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) [Phase 3]
Phase 3 TRAILBLAZER-ALZ 2 trial update for donanemab in early Alzheimer's disease with results posted in May 2024.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: MIcroglial Colony Stimulating Factor-1 Receptor (CSF1R) in Alzheimer's Disease [Phase 1]
A Phase 1 trial evaluating a CSF1R inhibitor for Alzheimer's disease and mild cognitive impairment was terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD) [Phase 3]
A Phase 3 trial evaluating long-term gantenerumab in Alzheimer's disease has been terminated, and results are now posted.
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Polymorphism of ApoE in Alzheimer's Disease: Genetic Study in Castile and Leon (Spain) [NA]
This clinical trial in Castile and Leon, Spain completed a genetic study examining ApoE polymorphisms in individuals with Alzheimer's diseas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: ALzheimer and MUsic THerapy: Effects of Music Lessons on Brain Plasticity, Mood, and Quality of Life in Alzheimer Patients [NA]
A clinical trial update describing ongoing research on music lessons as an intervention to affect brain plasticity, mood, and quality of lif…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease
A clinical trial is evaluating LEQEMBI (lecanemab) for its effects on cerebral and retinal amyloid in individuals with Mild Cognitive Impair…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: A Study to Evaluate XTR006 in Chinese Volunteers [Phase 1]
Phase 1 study evaluating XTR006 in Chinese volunteers with Alzheimer's disease has been completed.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Analysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD Subjects [NA]
A completed clinical trial update reporting analysis of the XTR006 PET imaging agent across non-cognitively impaired individuals, mild cogni…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease
A Korean brain aging study assessing early diagnosis and prediction of Alzheimer's disease has completed. The study included participants wi…
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: To Explore the Therapeutic Potential of Jiedu Yizhi Formula for Alzheimer 's Disease [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating the potential of the Jiedu Yizhi Formula for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-24Clinical Trial Update: An Investigation of Levetiracetam in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial investigating levetiracetam in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-23Clinical Trial Update: Home-based tDCS for Apathy in Alzheimer's Disease [NA]
A terminated clinical trial investigating home-based transcranial direct current stimulation (tDCS) for apathy in Alzheimer’s disease and re…
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 multiple-dose study of PF-04360365 in mild to moderate Alzheimer's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers [Phase 1]
Phase 1 study assessing systemic and ocular safety and pharmacokinetics of BI 409306 in schizophrenia, Alzheimer's disease, and healthy volu…
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update on a buccal film formulation of montelukast for patients with Alzheimer disease, reporting safety and efficacy…
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease [Phase 1, Phase 2]
Clinical trial update evaluating safety and potential therapeutic effects of CB-AC-02 in Alzheimer's disease across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: A Non-pharmacological Intervention for Patients With Alzheimer's Disease and Family Caregivers (Care Partners Program) [NA]
A completed clinical trial evaluating a non-pharmacological intervention for Alzheimer’s disease patients and family caregivers (Care Partne…
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: A Study to Evaluate the Pharmacodynamic (PD) Effects of Once Weekly Administration of Gantenerumab in Participants With Early Alzheimer's Disease (AD) [Phase 2]
Phase 2 study evaluating pharmacodynamic effects of once-weekly gantenerumab in early Alzheimer's disease was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Improving the Recovery and Outcome Every Day After the ICU [NA]
Completed clinical trial related to recovery and outcomes after ICU stay; conditions include delirium and Alzheimer disease, with results po…
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease [Phase 4]
Phase 4 trial update evaluating the efficacy and safety of choline alfoscerate in patients with Alzheimer disease.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer's Disease [Phase 2]
Phase 2 trial investigating crenezumab vs placebo in preclinical PSEN1 E280A mutation carriers with a tau PET longitudinal substudy; study c…
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: The BRAIN App: Building Relationships Using Artificial Intelligence and Nostalgia [NA]
A completed clinical trial titled The BRAIN App examining AI and nostalgia for dementia-related conditions; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: A Study to Evaluate Safety and Tolerability of Different Doses and Efficacy of PQ912 in Subjects With MCI and Mild AD [Phase 2]
A Phase 2 trial evaluating safety, tolerability, and efficacy of various doses of PQ912 in individuals with mild cognitive impairment and ea…
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Montelukast Therapy on Alzheimer's Disease [Phase 2]
Phase 2 trial of montelukast for Alzheimer's disease has completed with results posted.